Image 6_Pan-cancer analysis reveals ELFN1 as a novel prognostic biomarker and immunotherapeutic target associated with tumor microenvironment remodeling and promoting malignant phenotypes in colorectal cancer.tif
Background<p>Extracellular leucine rich repeat and fibronectin type III domain containing 1 (ELFN1), a transmembrane protein implicated in tumorigenesis and therapy resistance, remains mechanistically undefined as a pan-cancer target. In this study, we aimed to elucidate the function and poten...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Daljnji autori: | , , , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|